We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Paper-Based Electrochemical Device Analyses Glucose in Urine

By LabMedica International staff writers
Posted on 07 May 2012
A paper-based electrochemical system has been designed for flow-injection analysis of the concentration of glucose in urine samples. More...


Capillary wicking facilitates a gravity-driven flow of buffer solution continuously through paper and nitrocellulose, from a buffer reservoir at one end of the device to a sink at the other.

Scientists at the Vrije Universiteit (VU University; Amsterdam, The Netherlands) devised the instrument whereby difference in height between the reservoir and the sink leads to a continuous and constant flow. The nitrocellulose, on which glucose oxidase is immobilized, lies horizontally on a working electrode, which consists of a thin platinum layer deposited on a solid support. The counter and reference electrodes are strategically positioned upstream in the buffer reservoir.

A simple pipetting device was developed for reliable application of sub-microliter volumes of sample without the need of commercial micropipettes, which damage the nitrocellulose membrane. The system is based on amperometry, and the measured current is proportional to the glucose concentration. The system was tested for the determination of the concentration of glucose in 15 urine samples that had tested positive for glucose during routine analysis in the clinical laboratory. The concentration measured by the devise method resulted in a noninvasive, quantitative assay that could be used for diagnosis and monitoring of diabetes.

The system can also be used to measure glucose in other fluids, such as cell culture medium. Use of enzymes other than glucose oxidase, e.g., cholesterol oxidase, lactate oxidase, or d-3-hydroxybutyrate dehydrogenase, will enable the measurement of other metabolites, such as cholesterol, lactate, or d-3-hydroxybutyrate, respectively, making this system versatile for general clinical applications.

The authors concluded that this method does not require disposable test strips, with enzyme and electrodes that are thrown away after each measurement. Due to its low cost, this system could be used in medical environments that are resource-limited. The study was published on April 5, 2012, in the journal Analytical Chemistry.

Related Links:
Vrije Universiteit



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.